These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17408081)

  • 1. Screening systems.
    Reymond JL; Babiak P
    Adv Biochem Eng Biotechnol; 2007; 105():31-58. PubMed ID: 17408081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme assays for high-throughput screening.
    Goddard JP; Reymond JL
    Curr Opin Biotechnol; 2004 Aug; 15(4):314-22. PubMed ID: 15358001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of high throughput technology for the screening of natural products.
    Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
    Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry for enzyme assays and inhibitor screening: an emerging application in pharmaceutical research.
    Greis KD
    Mass Spectrom Rev; 2007; 26(3):324-39. PubMed ID: 17405133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable high-throughput functional screening with 3-FABS.
    Dalvit C; Ardini E; Fogliatto GP; Mongelli N; Veronesi M
    Drug Discov Today; 2004 Jul; 9(14):595-602. PubMed ID: 15239978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in biocatalyst discovery and optimization.
    Robertson DE; Steer BA
    Curr Opin Chem Biol; 2004 Apr; 8(2):141-9. PubMed ID: 15062774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-colony array based high throughput platform for enzyme library screening.
    Pohn B; Gerlach J; Scheideler M; Katz H; Uray M; Bischof H; Klimant I; Schwab H
    J Biotechnol; 2007 Mar; 129(1):162-70. PubMed ID: 17174002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR-based structural glycomics for high-throughput screening of carbohydrate-active enzyme specificity.
    Irague R; Massou S; Moulis C; Saurel O; Milon A; Monsan P; Remaud-Siméon M; Portais JC; Potocki-Véronèse G
    Anal Chem; 2011 Feb; 83(4):1202-6. PubMed ID: 21271685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Select protocols of high-throughput ee-screening systems for assaying enantioselective enzymes.
    Reetz MT
    Methods Mol Biol; 2003; 230():283-90. PubMed ID: 12824590
    [No Abstract]   [Full Text] [Related]  

  • 14. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput screening of purified proteins for enzymatic activity.
    Proudfoot M; Kuznetsova E; Sanders SA; Gonzalez CF; Brown G; Edwards AM; Arrowsmith CH; Yakunin AF
    Methods Mol Biol; 2008; 426():331-41. PubMed ID: 18542874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial biosynthesis for drug development.
    Menzella HG; Reeves CD
    Curr Opin Microbiol; 2007 Jun; 10(3):238-45. PubMed ID: 17553731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting QSAR models in lead optimization.
    Gedeck P; Lewis RA
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):569-75. PubMed ID: 18600573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening for integrative biomaterials design: exploring advances and new trends.
    Oliveira MB; Mano JF
    Trends Biotechnol; 2014 Dec; 32(12):627-36. PubMed ID: 25450043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.